XTX Topco’s Unicycive Therapeutics UNCY Stock Holding History
Bought
Maintained
Sold
Other funds holding UNCY
XTX Topco's UNCY Position: Q3 2026 in Review
XTX Topco increased its Unicycive Therapeutics (UNCY) stake by 615% in Q3 2026, buying an estimated $338K and bringing the position to 75,820 shares worth $356K. The position accounts for 0.01% of the portfolio, ranked #2648.
XTX Topco first reported a position in UNCY in Q2 2023 and has held it in 9 quarters since. 95 funds tracked by Wall St. Rank hold UNCY as of Q3 2026.
- XTX Topco held 75,820 shares of Unicycive Therapeutics worth $356K as of Q3 2026.
- XTX Topco bought 65,220 Unicycive Therapeutics shares in Q3 2026, an estimated $338K.
- Unicycive Therapeutics made up 0.01% of XTX Topco's portfolio in Q3 2026, its #2648 holding.
- XTX Topco first reported a position in Unicycive Therapeutics in Q2 2023 and has held it in 9 quarters since.
- 95 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q3 2026.
Based on XTX Topco's 13F filing for Q3 2026, filed 16 Nov 2026.